Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 16714-920

These are once-daily extended-release tablets containing 0.375 mg of Pramipexole Dihydrochloride. Each tablet should be taken whole without chewing, crushing, or dividing. The original unit of use container should be used for dispensing. The recommended dosage should be followed by reading the accompanying prescription information. The tablets should be stored in a cool and dry place, protected from high humidity, and kept away from children. Mackeods Pharmaceuticals Ltd., India, manufacture the tablets.*

This is a prescription medication with the brand name Pramipexole Dihydrochloride. It is an extended-release tablet that contains 0.75 mg of Pramipexole Dihydrochloride monohydrate per tablet. Each tablet should be swallowed whole and must not be chewed or divided. It should be stored at a temperature between 20°C to 25°C (66°F to 77°F). The medication comes in a container with 30 tablets. There is additional information written on the container. The information includes the dosage instructions, the manufacturer's name, and address, as well as a warning to keep it away from children.*

This is a description of a medication called Pramipexole Dihydrochloride Extended-Release Tablets which come in a unit of use container of 30 tablets. Each tablet contains 1.5mg of Pramipexole Dihydrochloride Monohydrate, equivalent to 1.41mg of Pramipexole Dihydrochloride USP. The tablets are to be swallowed whole and not to be chewed, crushed or divided, and must be stored at 20°C to 25°C, with excursions permitted to 15°C to 30°C, and protected from high humidity. More information about the dosage can be found in the accompanying prescribing information. The medication is manufactured in India by Macleods Pharmaceuticals Ltd.*

This is a medication with the National Drug Code 16714-919-01 that contains 2.25 mg of Pramipexole Dihydrochloride Extended-Release Tablets, dispensed in the original container with 30 tablets. It is necessary to swallow the tablets whole and not crush or divide them. The medication should be stored at 20° to 25°C (68°to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). It is manufactured for Northstar Rx LLC in Memphis, TN, and manufactured by Macleods Pharmaceuticals Ltd in India. *

This is a description of a medication called Pramipexole Tablets, which comes in extended-release tablets with each tablet containing 3.75mg of pramipexole dihydrochloride monohydrate, the equivalent of 3.53mg of pramipexole dihydrochloride, USP. The medication should be swallowed whole and not be chewed or crushed. It should be stored at 20° to 25°C and protected from high humidity. The tablets come in a container of 30 tablets and were manufactured by Macleods Pharmaceuticals Ltd in Badd, Himachal Pradesh, India for Northstar Rx LLC.*

This is a description of a medication with the NDC number 16714-920-01, called Pramipexole Dihydrochloride Extended-Release Tablets. The container comes with 30 tablets to be taken once daily. The dosage and relevant information are available in the accompanying prescribing information. Instructions on the container indicate that the tablets must not be chewed, crushed, or divided and should be swallowed whole. The tablets should be stored at controlled room temperature and protected from exposure to high humidity. The container has manufacturing details for Mackeods Pharmaceuticals Ltd. The rest of the text includes manufacturer information and a product code.*

This is a drug information sheet for Pramipexole Dihydrochloride Extended-Release Tablets, which contain 4.23 mg of Pramipexole Dihydrochloride, USP. The drug is taken orally once a day and should not be chewed, crushed, or divided. The tablets should be stored at controlled room temperature, between 20°C to 25°C, protected from high humidity, and out of reach of children. The drug is manufactured by Macleods Pharmaceuticals Ltd in India and distributed by Northstar Rx LLC in Memphis, TN.*